Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar Ikeydoc (< 20) Submitted: 7/4/2009 11:40:46 AM : Outperform Start Price: $29.95 AUXL Score: -84.92

Release of treatment for Dupuytrens Disease

Featured Broker Partners


Advertisement